Pfizer
Tom Cheslock has a diverse work experience in supply chain management. Tom is currently working as the Vice President of Global Supply Chain for Pfizer Hospital Supply since January 2022. Prior to this role, they served as the Head of North America Supply Chain for Pfizer Hospital Supply and as the Global Supply Chain Leader for Pfizer Consumer Health from 2012 to 2018.
Tom also worked at Wyeth Pharmaceuticals, where they held several senior positions. Tom was the Senior Director of Global Supply Chain Operations from 2008 to 2012, responsible for developing and executing the global supply chain transformation strategy. Tom also served as the Senior Director of Global Strategic Sourcing from 2006 to 2008, overseeing category management and supplier management programs. Additionally, they worked as the Director of Distribution Operations from 2003 to 2006, managing the distribution and logistics operations for the US and export to global affiliates.
Earlier in their career, Tom worked at Wyeth Pharmaceuticals as the Associate Director of Supply Network Planning from 2000 to 2002, overseeing production and supply chain activities for multiple pharmaceutical brands. Tom also gained experience as a Supply Chain Engineer at QVC and as an Engineer/Supply Chain professional at Ford Motor Co Electronics.
Overall, Tom Cheslock has a strong background in supply chain management, with experience in various leadership roles and expertise in strategic planning, transformation initiatives, and customer satisfaction.
Tom Cheslock earned a Bachelor's degree in Industrial Engineering from Penn State University - Main Campus, where they attended from 1988 to 1992. Tom then went on to pursue an MBA in Operations Management at the Fox School of Business at Temple University, graduating in 1996.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.